Skip to main content
Top
Published in: Breast Cancer Research and Treatment 1/2016

Open Access 01-07-2016 | Epidemiology

The recurrence pattern following delayed breast reconstruction after mastectomy for breast cancer suggests a systemic effect of surgery on occult dormant micrometastases

Authors: Hanna Dillekås, Romano Demicheli, Ilaria Ardoino, Svein A. H. Jensen, Elia Biganzoli, Oddbjørn Straume

Published in: Breast Cancer Research and Treatment | Issue 1/2016

Login to get access

Abstract

The purpose of this study was to characterize the recurrence dynamics in breast cancer patients after delayed reconstruction. We hypothesized that surgical reconstruction might stimulate dormant micrometastases and reduce time to recurrence. All mastectomy breast cancer patients with delayed surgical reconstruction at Haukeland University Hospital, between 1977 and 2007, n = 312, were studied. Our control group consisted of 1341 breast cancer patients without reconstruction. For each case, all patients in the control group with identical T and N stages and age ±2 years were considered. A paired control was randomly selected from this group. 10 years after primary surgery, 39 of the cases had relapsed, compared to 52 of the matched controls. The reconstructed group was analyzed for relapse dynamics after mastectomy; the first peak in relapses was similarly timed, but smaller than for the controls, while the second peak was similar in time and size. Second, the relapse pattern was analyzed with reconstruction as the starting point. A peak in recurrences was found after 18 months, and a lower peak at the 5th–6th year. The height of the peak correlated with the extent of surgery and initial T and N stages. Timing of the peak was not affected, neither was the cumulative effect. The relapse pattern, when time origin is placed both at mastectomy and at reconstruction, is bimodal with a peak position at the same time points, at 2 years and at 5–6 years. The timing of the transition from dormant micrometastases into clinically detectable macrometastases might be explained by an enhancing effect of surgery.
Literature
1.
go back to reference Brewster AM, Hortobagyi G, Broglio KR, Kau SW, Santa-Maria CA, Arun B, Buzdar AU, Booser DJ, Valero V, Bondy M, Esteva FJ (2008) Residual risk of breast cancer recurrence 5 years after adjuvant therapy. J Natl Cancer Inst 100(116):1179–1183CrossRefPubMed Brewster AM, Hortobagyi G, Broglio KR, Kau SW, Santa-Maria CA, Arun B, Buzdar AU, Booser DJ, Valero V, Bondy M, Esteva FJ (2008) Residual risk of breast cancer recurrence 5 years after adjuvant therapy. J Natl Cancer Inst 100(116):1179–1183CrossRefPubMed
2.
go back to reference Fisher B (1980) Laboratory and clinical research in breast cancer: a personal adventure: the David A Karnofsky memorial lecture. Cancer Res 40:3863–3874PubMed Fisher B (1980) Laboratory and clinical research in breast cancer: a personal adventure: the David A Karnofsky memorial lecture. Cancer Res 40:3863–3874PubMed
3.
go back to reference Demicheli R, Terenziani M, Valagussa P, Moliterni A, Zambetti M, Bonadonna G (1994) Local recurrences following mastectomy: support for the concept of tumor dormancy. J Natl Cancer Inst 86(1):45–48CrossRefPubMed Demicheli R, Terenziani M, Valagussa P, Moliterni A, Zambetti M, Bonadonna G (1994) Local recurrences following mastectomy: support for the concept of tumor dormancy. J Natl Cancer Inst 86(1):45–48CrossRefPubMed
4.
go back to reference Luzzi KJMI, Schmidt EE, Kerkvliet N, Morric VL, Chambers AF, Groom AC (1998) Multistep nature of metastatic inefficiency: dormancy of solitary cells after successful extravasation and limited survival of early micrometastases. Am J Pathol 153:865–873CrossRefPubMedPubMedCentral Luzzi KJMI, Schmidt EE, Kerkvliet N, Morric VL, Chambers AF, Groom AC (1998) Multistep nature of metastatic inefficiency: dormancy of solitary cells after successful extravasation and limited survival of early micrometastases. Am J Pathol 153:865–873CrossRefPubMedPubMedCentral
5.
go back to reference Ghajar CMPH, Mori H, Matei IR, Evason KJ, Brazier H, Almeida D, Koller A, Hajjar KA, Stainier DYR, Chen EI, Lyden D, Bissell MJ (2013) The perivascular niche regulates breast tumour dormancy. Nat Cell Biol 15(7):807–817. doi:10.1038/ncb2767 CrossRefPubMedPubMedCentral Ghajar CMPH, Mori H, Matei IR, Evason KJ, Brazier H, Almeida D, Koller A, Hajjar KA, Stainier DYR, Chen EI, Lyden D, Bissell MJ (2013) The perivascular niche regulates breast tumour dormancy. Nat Cell Biol 15(7):807–817. doi:10.​1038/​ncb2767 CrossRefPubMedPubMedCentral
6.
go back to reference Klauber-DeMore NVZ, LinkovI KJ, Brogen PI, Gerald WL (2001) Biological behavior of human breast cancer micrometastases. Clin Cancer Res 7:2434–2439PubMed Klauber-DeMore NVZ, LinkovI KJ, Brogen PI, Gerald WL (2001) Biological behavior of human breast cancer micrometastases. Clin Cancer Res 7:2434–2439PubMed
8.
go back to reference Naumov GAL, Folkman J (2006) Role of angiogenesis in human tumor dormancy: animal models of the angiogenic switch. Cell Cycle 5(16):1779–1787CrossRefPubMed Naumov GAL, Folkman J (2006) Role of angiogenesis in human tumor dormancy: animal models of the angiogenic switch. Cell Cycle 5(16):1779–1787CrossRefPubMed
9.
go back to reference Koebel CM, Vermi W, Swann JB, Zerafa N, Rodig SJ, Old LJ, Smyth MJ, Schreiber RD (2007) Adaptive immunity maintains occult cancer in an equilibrium state. Nature 450(7171):7903–7907CrossRef Koebel CM, Vermi W, Swann JB, Zerafa N, Rodig SJ, Old LJ, Smyth MJ, Schreiber RD (2007) Adaptive immunity maintains occult cancer in an equilibrium state. Nature 450(7171):7903–7907CrossRef
11.
go back to reference Ranganathan AC, Adam A, Aguirre-Ghiso JA (2006) Opposing roles of mitogenic and stress signaling pathways in the induction of cancer dormancy. Cell Cycle 5(16):1799–1807CrossRefPubMedPubMedCentral Ranganathan AC, Adam A, Aguirre-Ghiso JA (2006) Opposing roles of mitogenic and stress signaling pathways in the induction of cancer dormancy. Cell Cycle 5(16):1799–1807CrossRefPubMedPubMedCentral
12.
go back to reference Sosa MSBP, Debnath J, Aguirre-Ghiso JA (2013) Regulation of tumor cell dormancy by tissue microenvironments and autophagy. Adv Exp Med Biol 734:773–789 Sosa MSBP, Debnath J, Aguirre-Ghiso JA (2013) Regulation of tumor cell dormancy by tissue microenvironments and autophagy. Adv Exp Med Biol 734:773–789
13.
go back to reference Hanin LB-MS (2014) Reconstruction of the natural history of metastatic cancer and assessment of the effects of surgery: Gompertzian growth of the primary tumor. Math Biosci 247:248–257CrossRef Hanin LB-MS (2014) Reconstruction of the natural history of metastatic cancer and assessment of the effects of surgery: Gompertzian growth of the primary tumor. Math Biosci 247:248–257CrossRef
14.
go back to reference Demicheli RFM, Ambrogi F, Hiigins K, Boyd JA, Biganzoli E, Kelsey CR (2012) Recurrence dynamics for non-small-cell lung cancer, effect of surgery on the development of metastases. J Thorac Oncol 7:723–730CrossRefPubMed Demicheli RFM, Ambrogi F, Hiigins K, Boyd JA, Biganzoli E, Kelsey CR (2012) Recurrence dynamics for non-small-cell lung cancer, effect of surgery on the development of metastases. J Thorac Oncol 7:723–730CrossRefPubMed
15.
go back to reference Kelsey CRFM, Ambrogi F, Higgins K, Boyd JA, Biganzoli E, Demicheli R (2013) Metastasis dynamics for non-small-cell lung cancer: effect of patient and tumor-related factors. Clin Lung Cancer 14(4):425–432CrossRefPubMed Kelsey CRFM, Ambrogi F, Higgins K, Boyd JA, Biganzoli E, Demicheli R (2013) Metastasis dynamics for non-small-cell lung cancer: effect of patient and tumor-related factors. Clin Lung Cancer 14(4):425–432CrossRefPubMed
16.
go back to reference Fisher BGN, Saffer EA (1983) Influence of the interval between primary tumor removal and chemotherapy on kinetics and growth of metastases. Cancer Res 43:1488–1492PubMed Fisher BGN, Saffer EA (1983) Influence of the interval between primary tumor removal and chemotherapy on kinetics and growth of metastases. Cancer Res 43:1488–1492PubMed
17.
go back to reference Peeters CF, Wobbes dWR T, Westphal JR, Ruers TJ (2006) Outgrowth of human liver metastases after resection of the primary colorectal tumor: a shift in the balance between apoptosis and proliferation. Int J Cancer 119(6):1249–1253CrossRefPubMed Peeters CF, Wobbes dWR T, Westphal JR, Ruers TJ (2006) Outgrowth of human liver metastases after resection of the primary colorectal tumor: a shift in the balance between apoptosis and proliferation. Int J Cancer 119(6):1249–1253CrossRefPubMed
18.
go back to reference Curigliano GPJ, Bertolini F, Colleoni M, Peruzzotti G, de Braud F, Gandini S, Girlado A, Martella S, Orlando L, Munzone E, Pietri E, Luini A, Goldhirsch A (2005) Systemic effects of surgery: quantitative analysis of circulating basic fibroblast growth factor (bFGF), vascular endothelial growth factor (VEGF) and transforming growth factor beta (TGF-β) in patients with breast cancer who underwent limited or extended surgery. Breast Cancer Res Treat 93:35–40CrossRefPubMed Curigliano GPJ, Bertolini F, Colleoni M, Peruzzotti G, de Braud F, Gandini S, Girlado A, Martella S, Orlando L, Munzone E, Pietri E, Luini A, Goldhirsch A (2005) Systemic effects of surgery: quantitative analysis of circulating basic fibroblast growth factor (bFGF), vascular endothelial growth factor (VEGF) and transforming growth factor beta (TGF-β) in patients with breast cancer who underwent limited or extended surgery. Breast Cancer Res Treat 93:35–40CrossRefPubMed
19.
go back to reference Shao LOT, Sakamoo M, Mori S, Kodama T (2015) Activation of latent metastases in the lung after resection of a metastatic lymph node in a lymph node metastasis mouse model. Biochem Biophys Res Comm 460:543–548CrossRefPubMed Shao LOT, Sakamoo M, Mori S, Kodama T (2015) Activation of latent metastases in the lung after resection of a metastatic lymph node in a lymph node metastasis mouse model. Biochem Biophys Res Comm 460:543–548CrossRefPubMed
20.
go back to reference Dillekas H, Transeth M, Pilskog M, Assmus J, Straume O (2014) Differences in metastatic patterns in relation to time between primary surgery and first relapse from breast cancer suggest synchronized growth of dormant micrometastases. Breast Cancer Res Treat 146(143):627–736CrossRefPubMedPubMedCentral Dillekas H, Transeth M, Pilskog M, Assmus J, Straume O (2014) Differences in metastatic patterns in relation to time between primary surgery and first relapse from breast cancer suggest synchronized growth of dormant micrometastases. Breast Cancer Res Treat 146(143):627–736CrossRefPubMedPubMedCentral
21.
go back to reference Retsky MW, Demicheli R, Hrushesky WJ, Baum M, Gukas ID (2008) Dormancy and surgery-driven escape from dormancy help explain some clinical features of breast cancer. APMIS 116(117–118):730–741CrossRefPubMed Retsky MW, Demicheli R, Hrushesky WJ, Baum M, Gukas ID (2008) Dormancy and surgery-driven escape from dormancy help explain some clinical features of breast cancer. APMIS 116(117–118):730–741CrossRefPubMed
22.
go back to reference Lee JW, Shahzad M, Lin YG, Armaiz-Pena G, Mangala LS, Han HD, Kim HS, Nam EJ, Jennings NB, Halder J, Nick AM, Stone RL, Lu C, Lutgendorf SK, Cole SW, Lokshin AE, Sood AK (2009) Surgical stress promotes tumor growth in ovarian carcinoma. Clin Cancer Res 15(18):2695–2702CrossRefPubMedPubMedCentral Lee JW, Shahzad M, Lin YG, Armaiz-Pena G, Mangala LS, Han HD, Kim HS, Nam EJ, Jennings NB, Halder J, Nick AM, Stone RL, Lu C, Lutgendorf SK, Cole SW, Lokshin AE, Sood AK (2009) Surgical stress promotes tumor growth in ovarian carcinoma. Clin Cancer Res 15(18):2695–2702CrossRefPubMedPubMedCentral
23.
go back to reference Oosterling SJ, Van der Bij G, van Egmond M, van der Sijp JR (2005) Surgical trauma and peritoneal recurrence of colorectal carcinoma. Eur J Surg Oncol 31(31):29–37CrossRefPubMed Oosterling SJ, Van der Bij G, van Egmond M, van der Sijp JR (2005) Surgical trauma and peritoneal recurrence of colorectal carcinoma. Eur J Surg Oncol 31(31):29–37CrossRefPubMed
24.
go back to reference Morihara K, Takenaka H, Morihara T, Kishimoto S (2007) Primary cutaneous anaplastic large cell lymphoma associated with vascular endothelial growth factor arising from a burn scar. J Am Acad Dermatol 57(55):S103–S105CrossRefPubMed Morihara K, Takenaka H, Morihara T, Kishimoto S (2007) Primary cutaneous anaplastic large cell lymphoma associated with vascular endothelial growth factor arising from a burn scar. J Am Acad Dermatol 57(55):S103–S105CrossRefPubMed
25.
go back to reference Retsky M, Demicheli R, Hrushesky W, Baum M, Gukas I (2010) Surgery triggers outgrowth of latent distant disease in breast cancer: an inconvenient truth? Cancers (Basel) 30(32):305–337CrossRef Retsky M, Demicheli R, Hrushesky W, Baum M, Gukas I (2010) Surgery triggers outgrowth of latent distant disease in breast cancer: an inconvenient truth? Cancers (Basel) 30(32):305–337CrossRef
26.
go back to reference Demicheli RRM, Swartzendruber DE, Bonadonna G (1997) Proposal for a new model of breast cancer metastatic development. Ann Oncol 8(11):1075–1080CrossRefPubMed Demicheli RRM, Swartzendruber DE, Bonadonna G (1997) Proposal for a new model of breast cancer metastatic development. Ann Oncol 8(11):1075–1080CrossRefPubMed
27.
go back to reference Retsky MWDR, Swartzendruber DE, Bame PD, Wardwell RH, Bonadonna G, Speer JF, Valagussa P (1997) Computer simulation of a breast cancer metastasis model. Breast Cancer Res Treat 15(2):193–202CrossRef Retsky MWDR, Swartzendruber DE, Bame PD, Wardwell RH, Bonadonna G, Speer JF, Valagussa P (1997) Computer simulation of a breast cancer metastasis model. Breast Cancer Res Treat 15(2):193–202CrossRef
28.
go back to reference Isern AE, Manjer J, Malina J, Loman N, Mårtensson T, Bofin A, Hagen AI, Tengrup I, Landberg G, Ringberg A (2011) Risk of recurrence following delayed large flap reconstruction after mastectomy for breast cancer. Br J Surg 98(95):659–666CrossRefPubMed Isern AE, Manjer J, Malina J, Loman N, Mårtensson T, Bofin A, Hagen AI, Tengrup I, Landberg G, Ringberg A (2011) Risk of recurrence following delayed large flap reconstruction after mastectomy for breast cancer. Br J Surg 98(95):659–666CrossRefPubMed
29.
go back to reference Hölmich LRDM, Foged Henriksen T, Krag C, Brix Tange U, Kjøller K, McLaughlin JK, Olsen JH, Friis S (2008) Delayed breast reconstruction with implants after invasive breast cancer does not impair prognosis. Ann Plast Surg 61:11–18CrossRefPubMed Hölmich LRDM, Foged Henriksen T, Krag C, Brix Tange U, Kjøller K, McLaughlin JK, Olsen JH, Friis S (2008) Delayed breast reconstruction with implants after invasive breast cancer does not impair prognosis. Ann Plast Surg 61:11–18CrossRefPubMed
30.
go back to reference Registry TNC (2014) Nasjonalt kvalitetesregister for brystkreft-Årsrapport 2014. kvalitetsregistreno Registry TNC (2014) Nasjonalt kvalitetesregister for brystkreft-Årsrapport 2014. kvalitetsregistreno
31.
go back to reference Demicheli RAA, Miceli R, Valagussa P, Bonadonna G (1996) Time distribution of the recurrence risk for breast cancer patients undergoing mastectomy: further support about the concept of tumor dormancy. Breast Cancer Res Treat 41(2):177–185CrossRefPubMed Demicheli RAA, Miceli R, Valagussa P, Bonadonna G (1996) Time distribution of the recurrence risk for breast cancer patients undergoing mastectomy: further support about the concept of tumor dormancy. Breast Cancer Res Treat 41(2):177–185CrossRefPubMed
32.
go back to reference Marubini E, Valsecchi MG (2004) Analysing survival data from clinical trials and observational studies. Wilay, Chichester Marubini E, Valsecchi MG (2004) Analysing survival data from clinical trials and observational studies. Wilay, Chichester
33.
go back to reference Ramlau-Hansen H (1983) Smoothing counting process intensities by means of Kernel functions. Ann Stat 11:453–466CrossRef Ramlau-Hansen H (1983) Smoothing counting process intensities by means of Kernel functions. Ann Stat 11:453–466CrossRef
34.
go back to reference Boracchi PBE, Marubini E (2003) Joint modelling of cause-specific hazard functions with cubic splines: an application to a large series of breast cancer patients. Comput Statist Data Anal 42:243–262CrossRef Boracchi PBE, Marubini E (2003) Joint modelling of cause-specific hazard functions with cubic splines: an application to a large series of breast cancer patients. Comput Statist Data Anal 42:243–262CrossRef
35.
36.
go back to reference Demicheli RRM, Hrushesky WJM, Baum M, Gukas ID (2008) The effects of surgery on tumor growth: a century of investigations. Annal Oncol 19:1821–1828CrossRef Demicheli RRM, Hrushesky WJM, Baum M, Gukas ID (2008) The effects of surgery on tumor growth: a century of investigations. Annal Oncol 19:1821–1828CrossRef
37.
go back to reference Demicheli RRM, Hrushesky WJM, Baum M (2007) Tumor dormancy and surgery-driven dormancy interruption in breast cancer: learning from failures. Nat Clin Pract Oncol 4(12):699–710CrossRefPubMed Demicheli RRM, Hrushesky WJM, Baum M (2007) Tumor dormancy and surgery-driven dormancy interruption in breast cancer: learning from failures. Nat Clin Pract Oncol 4(12):699–710CrossRefPubMed
38.
go back to reference Antonio N, Bønnelykke-Behrndtz M, Ward L, Collin J, Christensen IJ, Steiniche T, Schmidt H, Feng Y, Martin P (2015) The wound inflammatory response exacerbates growth of pre-neoplastic cells and progression to cancer. EMBO J 34(17):2219–2236CrossRefPubMedPubMedCentral Antonio N, Bønnelykke-Behrndtz M, Ward L, Collin J, Christensen IJ, Steiniche T, Schmidt H, Feng Y, Martin P (2015) The wound inflammatory response exacerbates growth of pre-neoplastic cells and progression to cancer. EMBO J 34(17):2219–2236CrossRefPubMedPubMedCentral
40.
go back to reference Lindford AJ, Siponen E, Jahkola TA, Leidenius MH (2013) Effect of delayed autologous breast reconstruction on breast cancer recurrence and survival. World J Surg 37(12):2872–2882CrossRefPubMed Lindford AJ, Siponen E, Jahkola TA, Leidenius MH (2013) Effect of delayed autologous breast reconstruction on breast cancer recurrence and survival. World J Surg 37(12):2872–2882CrossRefPubMed
41.
go back to reference Platt JBN, McLaughlin J, Semple JL (2015) Does breast reconstruction after mastectomy for breast cancer affect overall survival? Long-term follow-up of a retrospective population-based cohort. Plast Reconstr Surg 135(3):468e–476eCrossRefPubMed Platt JBN, McLaughlin J, Semple JL (2015) Does breast reconstruction after mastectomy for breast cancer affect overall survival? Long-term follow-up of a retrospective population-based cohort. Plast Reconstr Surg 135(3):468e–476eCrossRefPubMed
42.
go back to reference Allawi Z, Cuzick J, Baum M, ATAC/LATTE investigators (2012) Does trauma or an intercurrent surgical intervention lead to a short-term increase in breast cancer recurrence rates. Ann Oncol 23(4):866–869CrossRefPubMed Allawi Z, Cuzick J, Baum M, ATAC/LATTE investigators (2012) Does trauma or an intercurrent surgical intervention lead to a short-term increase in breast cancer recurrence rates. Ann Oncol 23(4):866–869CrossRefPubMed
43.
go back to reference Langstein HNCM-H, Singletary SE, Robb GL, Hoy E, Smith TL, Kroll SS (2003) Breast cancer recurrence after immediate reconstruction: patterns and significance. Plastic Reconstr Surg 11(2):712–720CrossRef Langstein HNCM-H, Singletary SE, Robb GL, Hoy E, Smith TL, Kroll SS (2003) Breast cancer recurrence after immediate reconstruction: patterns and significance. Plastic Reconstr Surg 11(2):712–720CrossRef
44.
go back to reference Gieni M, Avram R, Dickson L, Farrokhyar F, Lovrics P, Faidi S, Sne N (2012) Local breast cancer recurrence after mastectomy and immediate breast reconstruction for invasive cancer: a meta-analysis. Breast 21(23):230–236CrossRefPubMed Gieni M, Avram R, Dickson L, Farrokhyar F, Lovrics P, Faidi S, Sne N (2012) Local breast cancer recurrence after mastectomy and immediate breast reconstruction for invasive cancer: a meta-analysis. Breast 21(23):230–236CrossRefPubMed
45.
go back to reference Eriksen CFJ, Wickman M, Lidbrink E, Krawiec K, Sandelin K (2011) Immediate reconstruction with implants in women with invasive breast cancer does not affect oncological safety in a matched cohort study. Breast Cancer Res Treat 127(2):439–446CrossRefPubMed Eriksen CFJ, Wickman M, Lidbrink E, Krawiec K, Sandelin K (2011) Immediate reconstruction with implants in women with invasive breast cancer does not affect oncological safety in a matched cohort study. Breast Cancer Res Treat 127(2):439–446CrossRefPubMed
46.
go back to reference Gordon NHCJ, Brumberg DJ, Berger NA (1992) Socioeconomic factors and race in breast cancer recurrence and survival. Am J Epidemiol 135(6):609–618PubMed Gordon NHCJ, Brumberg DJ, Berger NA (1992) Socioeconomic factors and race in breast cancer recurrence and survival. Am J Epidemiol 135(6):609–618PubMed
48.
go back to reference Sinicrope FA, Foster N, Yothers G, Benson A, Seitz JF, Labianca R, Goldberg RM, Degramont A, O’Connell MJ, Sargent DJ, Adjuvant Colon Cancer Endpoints (ACCENT) Group (2013) Body mass index at diagnosis and survival among colon cancer patients enrolled in clinical trials of adjuvant chemotherapy. Cancer 119(8):1528–1536CrossRefPubMedPubMedCentral Sinicrope FA, Foster N, Yothers G, Benson A, Seitz JF, Labianca R, Goldberg RM, Degramont A, O’Connell MJ, Sargent DJ, Adjuvant Colon Cancer Endpoints (ACCENT) Group (2013) Body mass index at diagnosis and survival among colon cancer patients enrolled in clinical trials of adjuvant chemotherapy. Cancer 119(8):1528–1536CrossRefPubMedPubMedCentral
Metadata
Title
The recurrence pattern following delayed breast reconstruction after mastectomy for breast cancer suggests a systemic effect of surgery on occult dormant micrometastases
Authors
Hanna Dillekås
Romano Demicheli
Ilaria Ardoino
Svein A. H. Jensen
Elia Biganzoli
Oddbjørn Straume
Publication date
01-07-2016
Publisher
Springer US
Published in
Breast Cancer Research and Treatment / Issue 1/2016
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-016-3857-1

Other articles of this Issue 1/2016

Breast Cancer Research and Treatment 1/2016 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine